Clinical Trial Update: High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-dose cytarabine and mitoxantrone followed by autologous transplantation for therapy-related myelodysplastic syndrome an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: University of Chicago | Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2013-06-24